CHK1, actif, son humain étiqueté, PRECISIO, recombinant, exprimé en cellules bactériulovirus infectées par le Sf9, > = 70 % (SDS-PAGE), solution de glycérol aqueuse tamponnée

Code: srp5278-10ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

CHK1 is a 56 kDa serine/threonine protein kinase that was originally identified in fission yeast to play a role in activation of the DNA damage checkpoint...


en savoir plus

Votre prix
$517.74 10UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

General description

CHK1 is a 56 kDa serine/threonine protein kinase that was originally identified in fission yeast to play a role in activation of the DNA damage checkpoint in the G2 phase of the cell cycle. CHK1 appears to function downstream of several of the known fission yeast checkpoint gene products, including that encoded by rad3+, a gene with sequence similarity to the ATM gene mutated in patients with ataxia telangiectasia.

Legal Information

PRECISIO is a registered trademark of Sigma-Aldrich Co. LLC

Physical form

Supplied in 50 mM sodium phosphate, pH 7.0, 300 mM NaCl, 150 mM imidazole, 0.1 mM PMSF, 0.2 mM DTT, 25% glycerol.

Preparation Note

After opening, aliquot into smaller quantities and store at -70 °C. Avoid repeating handling and multiple freeze/thaw cycles.

application(s)cell analysis
assay≥70% (SDS-PAGE)
biological sourcehuman
formbuffered aqueous glycerol solution
Gene Informationhuman ... CHEK1(1111)
mol wt~59 kDa
NCBI accession no.NM_001274
product linePRECISIO®
recombinantexpressed in baculovirus infected Sf9 cells
shipped indry ice
specific activity122-190 nmol/min·mg
storage temp.−70°C
Ce produit répond aux critères suivants: